Perspectives

8/26/2025 7:45:28 PM

Rapid Rundown: Latest on Marijuana Rescheduling from an FDA Perspective

By Daniel McGee Natalie Oehlers

President Donald Trump recently announced his intention to make a decision regarding potential changes to marijuana regulation,...

8/25/2025 5:42:54 PM

By Daniel McGee Natalie Oehlers

The U.S. Food and Drug Administration (FDA) has recently published a warning letter dated April 17, 2025, concerning the sale of various...

8/14/2025 1:44:23 PM

By Daniel McGee

Florida Attorney General (AG) James Uthmeier announced an emergency rule on August 13 to immediately stop the sale of 7-OH products at a...

8/5/2025 10:41:04 PM

By Dae Lee Lucas Morgan Natalie Crow

Pharmaceutical giants Novo Nordisk and Eli Lilly are intensifying their litigation strategies to safeguard their GLP-1 drugs, tirzepatide...

7/22/2025 8:31:29 PM

By Caitlin Collins Dae Lee Lucas Morgan

Established in 1992, the 340B Drug Pricing Program was designed to enable eligible healthcare providers, called covered entities, to...

7/22/2025 8:24:20 PM

By Caitlin Collins Dae Lee Lucas Morgan

Pharmacies across the United States operate under a complex web of regulations implemented and enforced by individual state Boards of...

6/27/2025 7:00:31 PM

By Lucas Morgan

An important reminder to Ohio-based Pharmacies and Pharmacists: As of May 1, 2025, new Rules and Regulations are in effect in Ohio...

5/30/2025 7:45:11 PM

By Daniel McGee

As reported in News Medical Life Sciences, researchers from the Salk Institute have created the most comprehensive, high-quality, and...

5/27/2025 4:55:57 PM

By Natalie Oehlers Carrie Amezcua Barbara Binzak Blumenfeld

Over the past several years, the Federal Trade Commission (FTC) has persistently been challenging what it deems to be improper patent...

5/13/2025 2:41:31 PM

By Daniel McGee

Although the bill still needs to pass the Texas Senate and ultimately be approved by the Senate, the Lone Star State has thrown down a...

4/21/2025 4:33:21 PM

By Jon Turpin

The emergence of artificial intelligence (AI) in drug development has significant ramifications for the pharmaceutical industry, patent...

4/8/2025 3:29:18 PM

By Daniel McGee

A bill being considered in the North Carolina State Senate would commit time and money to the study of psychoactive chemicals and...